Post-challenge glucose predicts coronary atherosclerotic progression in non-diabetic, post-menopausal women

Diabetic Medicine

Volumn 24, Issue 10, 2007, Pages 1156-1159

  Mellen, P B ^a   Bittner, V ^b   Herrington, D M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Atherosclerosis; Coronary angiography; Glucose intolerance; Post menopause

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; BLOOD VESSEL DIAMETER; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HORMONE SUBSTITUTION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POSTMENOPAUSE; PROGNOSIS; PROVOCATION TEST; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; CORONARY ANGIOGRAPHY; DISEASE PROGRESSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 34548771744     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02222.x     Document Type: Conference Paper

References (20)

1. Expert Panel on Detection, Evaluation Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001 285 : 2486 2497.
2. Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 : 3160 3167.
3. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH et al. Fasting and 2-h post-challenge serum glucose measures and risk of incident cardiovascular events in the elderly: The Cardiovascular Health Study. Arch Intern Med 2002 162 : 209 216.
4. Festa A, D'Agostino R Jr., Hanley AJG, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in non-diabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004 53 : 1549 1555.
5. Sasso FC, Carbonara O, Nasti R, Campana B, Marfella R, Torella M et al. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. J Am Med Assoc 2004 291 : 1857 1863.
6. 1c level. Diabetes Care 2000 23 : 1830 1834.
7. 1c. J Clin Epidemiol 2004 57 : 590 596.
8. Herrington DM, Reboussin DM, Klein KP, Sharp PC, Shumaker SA, Snyder TE et al. The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort. Controlled Clin Trials 2000 21 : 257 285.
9. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000 343 : 522 529.
10. Korpilahti K, Syvanne M, Engblom E, Hamalainen H, Puukka P, Ronnemaa T. Components of the insulin resistance syndrome are associated with progression of atherosclerosis in non-grafted arteries 5 years after coronary artery bypass surgery. Eur Heart J 19981 19 : 711 719.
11. Hurst RT, Lee RW. Increased incidence of coronary atherosclerosis in Type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 2003 139 : 824 834.
12. Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR et al. Postprandial glucose regulation: new data and new implications. Clin Ther 2005 27 : S42 56.
13. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with Type 2 diabetes. J Am Med Assoc 2006 295 : 1681 1687.
14. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004 35 : 1073 1078.
15. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial. J Am Med Assoc 2003 290 : 486 494.
16. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN et al. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). The MARS Research Group. Ann Intern Med 1993 119 : 969 976.
17. Janszky I, Mukamal KJ, Orth-Gomer K, Romelsjo A, Schenck-Gustafsson K, Svane B et al. Alcohol consumption and coronary atherosclerosis progression - the Stockholm Female Coronary Risk Angiographic Study. Atherosclerosis 2004 176 : 311 319.
18. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993 87 : 1067 1075.
19. Raggi P, Taylor A, Fayad Z, O'Leary D, Nissen S, Rader D et al. Atherosclerotic plaque imaging: contemporary role in preventive cardiology. Arch Intern Med 2005 165 : 2345 2353.
20. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998 21 : 518 524.